Case Report
Copyright ©The Author(s) 2025.
World J Clin Cases. Jul 16, 2025; 13(20): 104953
Published online Jul 16, 2025. doi: 10.12998/wjcc.v13.i20.104953
Table 1 Relevant laboratory indicators during treatment
Parameter
April 10, 2024 (admission)
April 24, 2024 (discharged)
White blood cell count (× 109/L)9.64.6
Neutrophils (%)75.659.2
Hypersensitive C-reactive protein (mg/L)64.22.3
Biochemical albumin (g/L)38.735.3
Alanine aminotransferase (U/L)2118
Aspartate aminotransferase (U/L)2624
Serum creatinine (μmol/L)133129
Estimated glomerular filtration rate (mL/minute/1.73 m2)3941
Table 2 Blood concentration of sulfamethoxazoleduring treatment
Date
April 19, 2024 (2 days after initiating SMZ)
April 21, 2024 (2 days after increasing the SMZ dose)
Blood SMZ concentration (μg/mL)5495